TLDRs;
- Microsoft introduces Copilot Health, allowing personalized medical insights while stock dips modestly.
- Platform integrates over 50 wearables and 50,000 hospitals for patient-centric AI tools.
- Copilot Health data is encrypted and isolated, prioritizing privacy and user control.
- AI-assisted visit prep may redefine clinical consultations but doesn’t replace doctors.
Microsoft has officially launched Copilot Health, a new AI-driven platform designed to provide personalized medical insights by aggregating a user’s health data. The service, which is opening a waitlist for adults aged 18 and older in the United States, allows users to pull information from over 50 wearable devices, including Apple Health, Oura, and Fitbit. In addition, it can access electronic health records from more than 50,000 hospitals and provider organizations via HealthEx, as well as lab results through Function.
The launch comes as Microsoft shares saw a slight decline in early trading, reflecting cautious investor sentiment despite the platform’s promise to transform patient engagement with AI tools. Analysts suggest the modest dip may be due to the uncertainty surrounding regulatory approvals and adoption rates for AI in personal healthcare.
Personalized Insights Without Replacing Doctors
Copilot Health is intended to help users prepare for clinical visits rather than replace medical care. Microsoft emphasizes that conversations and data within Copilot Health are fully isolated from general Copilot services, encrypted both at rest and in transit, and secured with strict access controls. Users can manage, delete, or disconnect their data at any time, and importantly, information from Copilot Health is not used to train Microsoft’s AI models.
The platform was developed with input from Microsoft’s internal clinical team and an external advisory panel of more than 230 physicians from 24 countries. It also carries ISO/IEC 42001 certification, highlighting its adherence to international standards for healthcare information security.
Integration Across Devices and Systems
Copilot Health functions as a patient-facing entry point for Microsoft’s broader healthcare ecosystem, which includes offerings for providers, insurers, and life sciences companies under the Microsoft for Healthcare umbrella. Tools such as Dragon Copilot, an AI assistant for clinical workflows, and Microsoft Cloud for Healthcare integrate with Copilot Health, enabling patients to connect with clinical and administrative systems where deployed.
A new feature within the Microsoft Copilot app will offer an AI concierge doctor—one that can access your medical records and health data, with your consent https://t.co/k87qTVYED9
— WSJ Tech (@WSJTech) March 12, 2026
Supporting technologies include Azure Health Data Services and AI models available through Microsoft Foundry, allowing developers to build secure healthcare applications. With these integrations, Copilot Health aims to provide a seamless experience for patients preparing for appointments while ensuring interoperability across multiple health platforms.
AI-Assisted Medical Visit Prep
Microsoft links Copilot Health to its MAI DxO research project, which explored AI-assisted medical diagnosis. In research settings, AI models demonstrated approximately 85% diagnostic accuracy compared with roughly 20% for physicians under the same conditions. While such results may pave the way for AI to act as a routine second opinion, Microsoft cautions that Copilot Health is strictly a preparatory tool and not a decision-making system for clinical care.
Legislation is already tightening around AI in healthcare. For instance, Illinois law prohibits AI from providing therapy or making independent clinical decisions. Government payers are also exploring AI to reduce spending on services deemed unnecessary, which may create tension between AI-supported patients and cost-driven healthcare systems.
Outlook for Microsoft and Healthcare AI
The introduction of Copilot Health reflects Microsoft’s strategy to expand its footprint in consumer healthcare while supporting providers and insurers with AI tools. Although the platform’s debut caused a slight retreat in MSFT stock, analysts see potential in long-term adoption as AI-assisted patient care becomes more widely accepted.





